Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 35 and 70 years old who have been diagnosed with a stroke affecting a specific area of the brain (the middle cerebral artery territory), confirmed by clinical assessment and brain imaging
- People who have weakness or partial paralysis on one side of the body as a result of their stroke
- People whose muscle stiffness and movement ability fall within specific ranges on two standard medical scales (Ashworth scale score of 2 or below, and Brunnstrom scale score of 4 or above — confirm with trial site)
- People with or without difficulty speaking or understanding language (aphasia) due to their stroke
- People who are 1 to 3 months past their hospital discharge following the stroke
- People of any sex who have had a stroke
- People who do not have cognitive impairment (thinking or memory problems) as a result of their stroke
- People who are willing to participate and sign a consent form — this can be signed by a family member or carer if needed
Who may not be able to join:
- People who develop dementia or other neurological or movement-related complications during the study
- People who have another stroke during the course of the research
- People who are unable to complete at least 90% of the treatment program
- People for whom a lack of family support or potential secondary gain is identified (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: María del Carmen Rojas-Sosa, Doctorado, Instituto Mexicano del Seguro Social
Phone: 55 5228 9917
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Functionality and disability of the paretic hemibody due to evento vascular cerebral (CVE) to the 3 weeks of treatment.; Functionality and disability of the paretic hemibody due to cerebro vascular event (CVE) to the 6 weeks of treatment.; Independency of patient with hemiparesis secondary to cerebro vascular event (CVE) to the 3 weeks of treatment.; Independency of patient with hemiparesis secondary to cerebro vascular event (CVE) to the 6 weeks of treatment.; Realization of the fine clamp of the plegia hand due to cerebro vascular event (CVE) to the 3 weeks of treatment.; Realization of fine...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.